CAMP compared with NERV: revenue, margins and what each company keeps, and the suppliers and customers both name

CAMPCamp4 Therapeutics Corp

Mkt capRevenueRevenue

NERVMinerva Neurosciences, Inc.

Mkt capRevenueRevenue

Compare

CAMPCamp4 Therapeutics Corp

NERVMinerva Neurosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CAMP1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+20.89%—

NERV2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±48.8%▲+5.22%×0.11

Q2 FY26±82.1%▼−3.83%×0.05

= impliedCAMP realized, solidNERV realized, hatchedOne scale, both sides: full bar = 83%× = |realized| ÷ impliedSource: market data

CAMPCamp4 Therapeutics Corp

4.70▲+15.67%

Mkt cap$320.5MRevenue$2MQ3 FY26Revenue$3MFY25

NERVMinerva Neurosciences, Inc.

2.62▲+8.12%

Regular sessionNov 9 '26

Mkt cap$120.6MRevenue—Revenue—

Compare

Regular sessionNov 9 '26

CAMPCamp4 Therapeutics Corp

NERVMinerva Neurosciences, Inc.

4.70▲+15.67%

Price

2.62▲+8.12%

$320.5M

Mkt cap

$120.6M

Q3 FY26$2M

Revenue

—

FY25$3M

Revenue

—

CAMP4.70▲+15.67%vsNERV2.62▲+8.12%Regular sessionNov 9 '26